MedPath

To evaluate the Safety and efficacy of Unani formulations in the treatment of (Pustules/Boils)

Phase 2
Conditions
Health Condition 1: null- Busoor-e-Jild (Pustules/Boils)Health Condition 2: L088- Other specified local infections of the skin and subcutaneous tissue
Registration Number
CTRI/2014/01/004283
Lead Sponsor
Central Council for Research in Unani Medicine CCRUM New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
300
Inclusion Criteria

1.Patients of either sex in the age group of 5 to 60 years.

2.Frequent occurrence of the following

3.Vesicles (a vesicle is a small blister, as on the skin. Vesicles are less than .5 centimeters in diameter)

4.Papules (Small solid rounded bumps rising from the skin that are each usually less than 1 centimeter in diameter (less than 3/8 inch across)

5.Pustules (Small solid rounded bumps rising from the skin that are each usually less than 1 centimeter in diameter (less than 3/8 inch across)

6.Macules (Flat , distinct, colored area of the skin less than 1 cm in diameter)

Exclusion Criteria

1. Age 5 years and 60 years

2.Patients with diseases/ disorders requiring long term treatment

3.Patients with Diabetes mellitus

4.Patients with other inflammatory skin conditions like localized abscess/ carbuncles/ boils.

5.Pregnancy and Lactation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in signs and symptomsTimepoint: 6 WEEKS
Secondary Outcome Measures
NameTimeMethod
Hematological and biochemical assessments for safetyTimepoint: 6 WEEKS
© Copyright 2025. All Rights Reserved by MedPath